Zyla Life Sciences Deferred Revenue (Non-Current)
Zyla Life Sciences had Deferred Revenue (Non-Current) of $16.51 million as of 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2016-03-11
- 2015-09-30: Deferred Revenue, Noncurrent $16.51M.
- 2015-06-30: Deferred Revenue, Noncurrent $16.70M.
- 2015-03-31: Deferred Revenue, Noncurrent $18.03M.
- 2014-12-31: Deferred Revenue, Noncurrent $8.86M.
| Period end | Deferred Revenue, Noncurrent | Deferred Revenue, Noncurrent as first filed |
|---|---|---|
| 2015-09-30 | $16.51M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $16.70M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $18.03M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $8.86M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $9.04M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $9.19M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $9.33M 10-Q · filed 2014-06-11 | |
| 2013-12-31 | $9.59M 10-K · filed 2015-03-16 | $10.15M 10-Q · filed 2014-06-11 |